The Gray Zone Strikes Again

Image-Guided Superficial Radiation Therapy (IGSRT) for non-melanoma skin cancer costs significantly more than Mohs micrographic surgery, prompting recent Medicare coding restrictions to limit medically unnecessary ultrasound simulations. Beyond surgical costs, clinical research identifies "satellite nevi"—moles located within five millimeters of one another—as a potential independent risk factor for melanoma, warranting further investigation into their role in patient screening. While high-dose UV radiation remains a primary driver of skin cancer, low-dose exposure studies suggest that human skin effectively repairs DNA damage from brief, non-burning sunlight, offering a more nuanced perspective on sun safety. Additionally, tofacitinib serves as a cost-effective, off-label alternative for treating severe alopecia areata, while teledermatology and AI-driven monitoring tools provide outcomes comparable to in-person care for managing chronic inflammatory conditions like atopic dermatitis and psoriasis.